The Chinese medical device market may triple by 2018, partially due to high rates of tobacco consumption and a rapidly growing economy, according to a market report.
Deals Roundup
MAKO’s plunge may be good news for buyers | Wall Street Beat
Mako Surgical (NSDQ:MAKO) has had a tough month on Wall Street, with shares having lost 45% since the end of April, but not everyone is running for the hills.
Earlier this week a company director, Frederick Moll, picked up another 5,000 shares at $24.15 each, representing the 1st insider buy on the open market since late last year.
Agilent’s $2.2B all-cash bid for Dako is largest in company history | MassDevice.com On Call
MASSDEVICE ON CALL — Agilent Technologies (NYSE:A) doled out more than $2 billion in cash to acquire Dako, a Denmark-based cancer diagnostic company with more than 1,000 employees with a foothold in more than 100 countries.
The deal, intended to grow Agilent’s life sciences business, is the largest in the company’s history, according to a press release.
Kensey Nash shareholders sue to block Royal DSM merger | Legal News
HeartWare closes enrollment in destination therapy trial for heart pump | Wall Street Beat
HeartWare International (NSDQ:HTWR) completed enrollment in a 450-patient pivotal trial considering its ventricular assist system as a destination therapy for patients with advanced heart failure.
Boston Scientific’s CEO defends the troubled Guidant buyout | Wall Street Beat
Boston Scientific’s (NYSE:BSX) interim CEO Hank Kucheman still believes in the company’s ill-fated acquisition of Guidant Corp., a deal worth $26 billion that was followed by recalls, lawsuits and criminal charges.
Smith & Nephew eyes Brazil as $150 million market | Wall Street Beat
Smith & Nephew (NYSE:SNN) is looking to increase business in Brazil 7-fold, as part of its new emerging markets strategy.
CEO Olivier Bohuon told investors this week that business at the British orthopedic giant is growing at a 20% clip in China and India, but the firm is eyeing Brazil as the next growth driver for the company.
J&J nabs its 1st Chinese device maker | Wall Street Beat
Health care giant Johnson & Johnson (NYSE:JNJ) made its 1st acquisition in China this week, picking up Guangzhou Bioseal Biotech for an undisclosed amount.
J&J has been doing business in China for more than 25 years, including last year’s launch of a medical device and diagnostics innovation center there.
More deals ahead for Covidien? | Wall Street Beat
Philips launches telemedicine deal with Vidyo | Wall Street Beat
Technology titan Philips Healthcare (NYSE:PHG) launched a new telemedicine initiative through a partnership with Vidyo, a New Jersey-based videoconferencing technology provider with a foot in the door at hospitals around the world.